This $95,931.00 firm fixed price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the provision of a MiSeq System, a genetic analysis platform used in life science research, applied markets, and molecular diagnostics. Illumina has a history of providing sequencing systems and consumables to support...
This is a $95,931.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract is for the purchase of an Illumina MiSeq2 sequencing system and associated components. Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, is the prime contractor. This contract does not have a set-aside designation. Illumina has provided...
This is a firm fixed price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc. for invoice and payment provisions related to the procurement of Illumina sequencing systems and associated products. The order has a ceiling value of $83,821.84 and an ultimate completion date of September 2, 2020. Illumina, a manufacturer of genetic analysis equipment and reagents, has previously been awarded prime federal contracts and...
This is a $90,997.20 firm fixed-price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract is for the supply of an MISEQ I100 PLUS SYSTEM, with a period of performance running through December 12, 2025. This contract was not set aside for any specific business type. Illumina holds several other federal Indefinite...
This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
This is a $11,044.52 firm fixed price purchase order awarded by the National Eye Institute, a component of the National Institutes of Health, to Illumina, Inc. The contract is for the provision of Illumina's genetic sequencing and analysis instruments, reagents, and associated support services. This includes NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables and bioinformatics products. The contract has an ultimate completion date of June 24, 2025 and does not...
This firm fixed-price delivery order was awarded by the National Institute of Environmental Health Sciences (NIEHS), part of the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $77,654.45 contract is for the provision of various Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with accompanying reagents, consumables, sample prep kits, sequencing chips,...
This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The award, valued at $135,908.52, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
This is a $141,129.90 firm fixed price purchase order contract awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for the provision of an ILLUMINA MISEQ FGX sequencing system. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has provided similar products and services to support genomic research and diagnostics for federal agencies like the NIH, CDC,...